Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pharmacology Nursing 3703 By Linda Self.  Pregnancy is dynamic state with legion of physiologic changes  Maternal-placental-fetal circulation— drugs.

Similar presentations

Presentation on theme: "Pharmacology Nursing 3703 By Linda Self.  Pregnancy is dynamic state with legion of physiologic changes  Maternal-placental-fetal circulation— drugs."— Presentation transcript:

1 Pharmacology Nursing 3703 By Linda Self

2  Pregnancy is dynamic state with legion of physiologic changes  Maternal-placental-fetal circulation— drugs readily cross placenta  Placental transfer occurs by fifth week of gestation

3  Drugs enter fetal circulation, are active as fetus has low levels of albumin, thus low drug binding  Drugs to liver slowly metabolized due to immaturity of liver  Drugs excreted by kidney into amniotic fluid where fetus swallows  Blood-brain barrier poorly developed so many drugs readily cross

4  Can use knowledge of maternal-fetal circulation to deliver meds to fetus  Examples include: digoxin for fetal tachycardia, Synthroid for hypothyroidism, PCN for exposure to syphilis, corticosteroids to accelerate surfactant production in preemies

5  Give meds only when absolutely necessary  Drugs chosen should be based on stage of pregnancy and known information  Any drugs used should be in the lowest possible dosages  Live viral vaccines should be avoided due to possible harm to fetus

6  Drug teratogenicity likely to occur 1 st trimester  2 nd and 3 rd trimester effects vary. May result in growth retardation, respiratory problems, infection, bleeding or congenital heart problems

7  Drugs taken at any time during pregnancy can affect baby’s brain because brain development continues throughout pregnancy and after birth

8  Folic acid supplementation important to prevent neural tube defects  All women of childbearing potential should ingest 440-600 mcg of folic acid from food +/or supplement  Pregnancy, need 800mcg  Ginger is ok for nausea

9  A—studies in pregnant women reveal no risk  B—animal studies reveal no risk to fetus  C—risk unknown  D—positive evidence harm  X—contraindicated, risks outweigh benefits

10  Coumadin—spontaneous abortion, congenital anomalies. Heparin is anticoagulant of choice in pregnancy.  Anticonvulsants-high rate of abnormalities. Dilantin, Tegretol, Depakote are category D.

11  NSAIDs can cause congenital heart abnormalities. Cat. D.  ASA associated with bleeding. Cat. D.  Cautious use of antihypertensives. Methyldopa for hypertension in pregnancy.  May see hydralazine or labetalol in acute situations.

12  ACE inhibitors and ARBs contraindicated. Can cause renal defects, craniofacial abnormalities, fetal limb abnormalities. Ex. Enalapril, captopril, amlodipine.  Antibiotics considered acceptable: azithromycin, cephalosporins, penicillins, clindamycin, erythromycin

13  TCAs Cat. D  Some SSRIs Cat. C but studies reveal relationship w/heart defects, craniosynostosis, anencephaly  Insulin is treatment of choice for diabetics in pregnancy. Not aspart or glargine.  Lithium—cardiac defects, thyroid abnormalities

14  Anemias: iron deficiency, physiologic and megaloblastic  Iron supplements may be appropriate if iron deficiency anemia  Folic acid supplementation in megaloblastic anemia

15  Constipation secondary to decreased peristalsis, increasing uterine weight on intestines  Treat with psyllium, docusate or MOM

16  GERD-increased abdominal pressure, relaxed esophageal sphincter. Small meals, avoid caffeine, may give Zantac if necessary. Avoid PPIs.  No Pepto-Bismol

17  Gestational diabetes-tested weeks 24-28  Tx with nutrition and exercise  If needed, best to use insulin or acarbose (decreases digestion of CHO in gut)

18  Nausea and vomiting—crackers when awakening  Vitamin B6 may help  Zofran and Reglan both Category B

19  Grp B streptococcus-do vaginal culture at 35-37 weeks. If positive, tx with antibiotics at onset of labor until delivery.  HIV-HAART. Goal is to achieve RNA load <400 copies/ml.  Tx reduces transmission to fetus by 2/3s.  During labor, treat with IV zidovudine.

20  Treat infant of HIV+ mother with zidovudine for 6 weeks  Children with HIV infection, treat with Bactrim by 4-6 weeks  UTIs—treat asymptomatic bacteriuria to prevent preterm deliveries, cystitis and pyelonephritis. Macrodantin, possibly cephalosporin or pcn.

21  Abortion is termination of pregnancy before 20 weeks gestation  Prostaglandins stimulate uterine contractions—can be used to induce abortion  Cytotec (misoprostal) often used to tx gastric ulcers. PO or intravaginally to induce parturition

22  Drugs used to inhibit labor and maintain pregnancy  Uterine contractions between <37 weeks with cervical changes are considered premature  Tocolytics may prolong pregnancy in order to provide steroids (resp. develop.)  Can use nifedipine, terbutaline, Indocin  Magnesium sulfate under debate but still used

23  Oxytocin stimulates uterine contraction and “let-down”  Pitocin is synthetic form of oxytocin  May be used to induce labor and/or control uterine bleeding after delivery or to complete incomplete abortion

24  Parenteral opioids used to control pain during labor and delivery  Morphine, meperidine, fentanyl  Meperidine less neonatal resp. depression  Stadol (butorphanol)  Epidural analgesics—Duramorph, fentanyl, morphine  Epidural anesthetics-bupivacaine

25  Ophthalmia neonatorum can cause blindness. Chlamydia trachomatis. EES to each eye at birth. Also useful for GC.  Vitamin K is administered to prevent hemorrhagic disease. Infant has immature liver, lack intestinal bacteria (synthesize vitamin K). One dose of phytonadione 0.5 to 1mg.

26  Most systemic drugs taken by mother reach infant in breast milk  Women with HIV should not breast feed

27  Endogenous estrogens and progesterone synthesized from cholesterol  Estrogen synthesis in adipose tissue may be significant source of estrogen. Requires a minimum body weight and fat content (16-24%)  Interrelationship of estrogens and progesterone on each others receptors

28  Composed of three types  Estradiol major estrogen  Purpose—promotes growth in tissues r/t reproduction and sexual characteristics in women  Menstrual cycle—1 st half, increasing levels of estrogens, 2 nd half, estrogen and progesterone continue to rise then stop abruptly. Endometrium then sloughs.

29  Placenta produces large amounts of estrogen during pregnancy  Causes enlargement of uterus, growth of glandular tissue in the breasts, broaden pelvis

30  Secreted by corpus luteum  Cause changes in second half of cycle which provide for implantation and nourishment of a fertilized ovum  If ovum is fertilized, progesterone acts to maintain pregnancy

31  Corpus luteum produces progesterone during first weeks of gestation  Placenta then takes over  Progesterone prepares breasts for lactation by promoting development of milk-producing cells  Synthetic progestins affect LDL and HDL and may decrease glucose tolerance

32  Act by: 1. Inhibit hypothalamic secretion of gonadotropin releasing hormone, in turn inhibits FSH and LH. No ovulation thus no conception. 2. Produce cervical mucous that resists penetration of sperm into reproductive tract 3. Affect endometrial maturation and reception of ova

33  Component of birth control pills and other preparations for women 12-45  Contraindicated in pregnancy  Relieve vasomotor symptoms r/t estrogen deficiency===ERT  HRT—no unopposed estrogen  For delayed sexual development  DUB  Debate is on whether benefits outweigh risks

34  Oppose estrogen  Suppress ovarian function in dysmenorrhea, endometriosis, endometrial cancer and DUB  Debate on whether therapeutic or too many risks

35  Control fertility and prevent pregnancy  Contraception after “unprotected” sex  Menstrual disorders (amenorrhea, dysmenorrhea)

36  Known or suspected pregnancy— teratogenic  Thromboembolic disorders  Cancers of breast or genital tissues  Undiagnosed vaginal or uterine bleeding  Fibroid tumors  Altered liver function  Gallbladder disease

37  History of cerebrovascular disease, coronary artery disease, thrombophlebitis, hypertension  Women over 35 yo who smoke  Family history of breast or reproductive system cancer

38  Conjugated estrogens (synthetic) Cenestin  Conjugated estrogens –Premarin  Estradiol-Estrace  Estradiol hemihydrate—Vagifem  Estradiol transdermal—Estraderm, Climara, Vivelle  Estrone—injection weekly

39  Palliative in metastatic breast cancer (when anti-estrogens become less effective)  Black box warning: estrogen w or w/o progestins increase lipids, coagulation and possibly promotion of cancer

40  With minimal androgenic effects include: desogestrel, norgestimate  Intermediate androgenic activity: norethindrone and ethynodiol  High androgenic activity : norgestrel

41  Depo-Provera and Provera (medroxyprogesterone)  Megace (megestrol acetate)  Aygestin (norethindrone acetate)

42  Micronized for oral use  Does not have the negative lipid panel effects  For amenorrhea, DUB  Oppose estrogens in women with intact uterus

43  Usually contain a synthetic estrogen and a synthetic progestin  Monophasic—fixed amounts of estrogen and progestins  Biphasics—fixed amounts of estrogen with varying doses of progestins  Triphasics—varied amounts of both estrogen and progestins

44  Monophasics—Alesse, Loestrin, Ortho- Novum, Yasmin, Yaz, Zovia, many more  Biphasics—Mircette, Ortho-Novum  Triphasics—Estrostep, Tri-Levlen, Triphasil  *(with varying levels of hormones, fewer side effects)  Progestin Only—Depo-Provera, Ortho- Evra, others

45  Implanon—progestin only, 3 years, single rod  Mirena—IUD impregnated with levonogestrol, 5 years

46  Reason for use  Desired route  Duration of action  Transdermal estradiol –decreases dosage needed, more like natural level  Progestin component can cause acne, weight gain, lipid levels

47  Anti-seizure medications and antibiotics can decrease effectiveness of the OCP  Estrogens can decrease effectiveness of sulfonylurea antidiabetic drugs (increase their metabolism)  Warfarin effectiveness decreased  Decreased Dilantin (phenytoin) effectiveness

48  Plan B (levonorgestrel)  Only product on market for avoidance of pregnancy after unprotected intercourse  Most effective within 24h and <72h  Inhibits ovulation  No effect on pregnancy after implantation

49  Vasomotor s/s  ? Memory  Bone health  GU health

50  Inability to conceive after 12 months of contraceptive-free intercourse  1 in 10 couples degree of infertility  May opt for ovulation induction by use of Ovid (HCG choriogonadotropin alpha— like LH) used with Pergonal (menotropins—contains both FSH and LH)

51  Clomid (clomiphene) is nonsteroidal estrogen receptor modulator  Inhibits negative feedback mechanism of hypothalamus by competition with receptors  Signals hypothalamus to release gonadotropin releasing hormone>>>increases FSH and LF>>promotes follicular maturation and ovulation

52  Preparation of human gonadotropins FSH and LH. Once follicles ripen, hCG is administered.  Use this drug when gonadotropin secretion is insufficient  Adverse effects: ovarian enlargement, multiple births, spontaneous abortion

53  Usually produced by placenta  Similar in action to LH  Exogenous use induces ovulation in owmne who have ovulatory failure

54  Testosterone primary male sex hormone  Secreted by Leydig’s cells  Instrumental in development of male sexual characteristics, reproduction, and metabolism

55  Male sexual characteristics  Promotes stimulus for descent of testes into the scrotum—usually after 7 th month of pregnancy  11-13 years, surge of testosterone  Consistent secretion until about 50  Skin thickens, body hair, bones thicken, laryngeal enlargement, skeletal muscle (slows loss of N+ and amino acids)

56  Synthetic drugs with increased anabolic activity and decreased androgenic activity in relation to testosterone  Used for tissue building and growth stimulating effects  For cryptorchidism  Schedule III

57  Indications:  Low testosterone levels in males (see text)  Muscle wasting as seen in HIV/AIDS  Delayed puberty  For growth stimulation  To increase libido

58  Serious side effects: 1. Fluid retention 2. hyperglycemia 3. Decreased testicular function and impotence 4. Liver disorders—neoplasms, cholestatic hepatitis 5. HTN, elevated LDL, decreased HDL 6. Heart damage 7. Aggression, hostility, combativeness 8. May cause premature baldness

59  Depo-testosterone  Androgel (testosterone gel)  Android (methyltestosterone) cryptorchidism  Androderm (testosterone transdermal)  Danazol endometriosis

60  During pregnancy  Liver disease  Prostate disease

61  In up to 42% of men ages 40-70 yo  Multi-causation

62  With stimulation, acetylcholine enhances production of nitric oxide  Nitric oxide activates activity of enzymes>>cGMP (vasodilatory)  Inflow of blood increases secondary to this relaxation Also with secondary effect on cAMP which contributes to an erection

63  Cause decreased catabolism of cGMP (concentrated in genital tissue)  Cause increasing cAMP which results in an increase of arterial blood flow to corpora

64  DM, HTN, depression  History of dysfunction  Use of testosterone is indicated for decreased libido

65  Concurrent use of nitrates  Concurrent use of alpha adrenergic blocking agents like Flomax (tamsulosin), Hytrin (terazosin)  Cautin in those with cavernosal fibrosis, Peyronie’s

66  Viagra (sildenafil)  Cialis (tadalafil)  Levitra (vardenafil)

67  Adjust doses in those over 65, in those with renal or hepatic disease or those taking EES, ketoconazole, cimetadine, antiretrovirals  SE—HA, blue vision, nasal congestion, dyspepsia, dizziness  Ensure is cardiovascularly fit to take med

68  Yohimbe—psychoactive, aphrodisiac  Ginseng—increases energy and resistance  Multiple herbals

Download ppt "Pharmacology Nursing 3703 By Linda Self.  Pregnancy is dynamic state with legion of physiologic changes  Maternal-placental-fetal circulation— drugs."

Similar presentations

Ads by Google